TipRanks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
Want to see VRTX full AI Analyst Report?

Compare Vertex Pharmaceuticals (VRTX) vs. Competitors

6,811 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
$547.29
$133.37B
30.38
37.79%
21 Buy
3 Hold
1 Sell
Strong Buy
Alnylam Pharma
$240.08
$34.25B
41.96
-43.07%
18 Buy
3 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$11.66B
158.58
14.52%
17 Buy
5 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$1.97B
-12.97
5.36%
4 Buy
8 Hold
4 Sell
Hold
Intellia Therapeutics
$13.51
$1.65B
-3.50
-29.26%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.24B
-11.39
-10.10%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRTX
Vertex Pharmaceuticals
526.19
130.88
33.11%
ALNY
Alnylam Pharma
255.96
-191.53
-42.80%
BMRN
BioMarin Pharmaceutical
60.26
6.24
11.55%
SRPT
Sarepta Therapeutics
18.67
-0.15
-0.80%
NTLA
Intellia Therapeutics
11.75
-5.17
-30.56%
CRSP
Crispr Therapeutics AG
54.23
-9.54
-14.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts